Table 1.
Baseline characteristics of patients.
| Characteristics | Overall (n = 36) |
|---|---|
| Age, median | 70 (60.75–76.75) |
| Gender, male/female | 31/5 |
| Etiology: HCV/HBV/NBNC | 10/6/20 |
| Albumin, median (g/dL) | 3.800 (3.625–4.100) |
| Total bilirubin, median (mg/dL) | 0.600 (0.500–0.975) |
| ALBI score, median | −2.590 (−2.827–−2.267) |
| FIB4 index, median | 2.778 (1.644–5.191) |
| BCLC stage, B/C | 9/27 |
| Vascular invasion, with/without | 5/31 |
| Extrahepatic spread, with/without | 26/10 |
| Baseline AFP, median (ng/mL) | 76.5 (5.25–11543.5) |
| DCP, median (mAU/mL) | 1303.5 (43.25–7394.3) |
HCV, hepatitis C virus; HBV, hepatitis B virus; NBNC, HBV and HCV negative; BCLC, Barcelona Clinic Liver Cancer; ALBI grade, albumin-bilirubin grade; FIB4, The fibrosis-4 (FIB-4) index was calculated as age (year) × AST (IU/L) / (platelet count (109/L) × √ALT (IU/L)) [38]; AST, aspartate aminotransferase; ALT, alanine aminotransferase; AFP, α-fetoprotein concentration; DCP, Des-γ-carboxy prothrombin. We express the inspection value in Median (interquartile range).